Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis

Fig. 2

Bupivacaine restrains the aerobic glycolysis of gastric cancer cells. a-c AGS and HGC27 cells were exposed to 10 μg/mL Bupivacaine for 48 h. a and b Glucose, Oligomycin and 2-DG were sequentially injected. The ECAR was analyzed using the Seahorse XF 96 Extracellular Flux Analyzer to identify the glycolysis and glycolytic capacity. c Western blot assay was conducted to detect the expression of GLUT1 and LDHA in AGS and HGC27 cells treated with 10 μg/mL Bupivacaine for 48 h or not. **P < 0.01, ***P < 0.001

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us